Immunyx Pharma

About

Funding history · 1 round · — total

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Immunyx Pharma's primary focus in drug development?

Immunyx Pharma is a drug development company focused on modulating neutrophil function to treat disease, utilizing a platform technology to manipulate neutrophils with targeted nanoparticles.

When was Immunyx Pharma founded?

Immunyx Pharma was founded in February 2021.

What was Immunyx Pharma's former name?

Immunyx Pharma was formerly known as NEUTROPHIX.

Where is Immunyx Pharma headquartered?

Immunyx Pharma is headquartered in Jerusalem, Israel.

Which investor participated in Immunyx Pharma's undisclosed funding round in March 2021?

VLX Ventures participated in Immunyx Pharma's undisclosed funding round in March 2021.

What is the current employee count for Immunyx Pharma?

Immunyx Pharma currently has 6 employees.

What is the origin of Immunyx Pharma's neutrophil-targeting technology?

Immunyx Pharma's neutrophil-targeting technology is based on research by professors Zvika Granot and Zvi Fridlender at the Hebrew University.

What is an example of a technology success story associated with Immunyx Pharma?

In February 2021, a technology success story titled "Targeting Neutrophils as a Therapy for Severe COVID-19 Infection" was associated with Immunyx Pharma, focusing on cell-therapy and targeted-therapy within Pharmaceuticals & Diagnostics.

Sectors & technology

Tags